MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Combination With Revlimid (and Dexamethasone)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Pethema Multiple Myeloma 2000
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1
Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2